A standard vitamin D blood test reports total 25-hydroxyvitamin D, the storage form the liver makes from either D2 or D3, and that marker is listed as Vitamin D (25-OH). A typical lab reference range runs 30 to 100 ng/mL, while FitScript's optimal range for this marker is 50 to 80 ng/mL. Optimal ranges of that kind are optimization targets rather than diagnostic cut-offs, and reference ranges vary by lab, age and sex. One value is an observation, not a conclusion about your health. The parent guide linked above covers how the test is run and what high and low results may reflect. The rest of this page answers the narrower question, which is how D2 and D3 differ and why that difference shows up on both a label and a lab report.
Because two different organisms make it by the same trick, starting from two different raw materials. Vitamin D is a secosteroid, meaning it is a steroid molecule with one ring broken open, and ultraviolet light is what breaks it. In fungi and yeast, the starting material is ergosterol, and ultraviolet light converts it to ergocalciferol, labelled D2. In the skin of humans and other animals, the starting material is 7-dehydrocholesterol, and ultraviolet B light converts it to previtamin D3, which rearranges into cholecalciferol, labelled D3.
The two end products are nearly identical. The difference sits in the side chain, where D2 carries an extra double bond and an extra methyl group. That looks trivial on paper, but enzymes and transport proteins are shape readers, and a small change in shape can change how tightly a molecule is carried in the blood and how quickly it is broken down. This is the structural reason the two forms are not interchangeable in practice even though both are genuinely vitamin D.
The numbering also confuses people. There is no vitamin D1 on the shelf because the compound originally given that name turned out to be a mixture rather than a single substance, so the name was retired. That left D2 and D3 as the two forms used in food, fortification and supplements.
Practically, this means a label reading simply "vitamin D" is incomplete information. The ingredient line tells you which form is actually inside, usually written as cholecalciferol or ergocalciferol.
D3 comes from animals and from your own skin, while D2 comes from fungi and yeast. Sunlight on bare skin produces D3 and only D3. In food, D3 is concentrated in oily fish such as salmon, sardines and mackerel, and appears in smaller amounts in egg yolk, liver and cod liver oil. Most fortified dairy and many fortified cereals and juices use D3 as well, although fortification practice varies by product and by country.
D2 shows up in mushrooms, particularly mushrooms deliberately exposed to ultraviolet light, and in yeast-derived ingredients. Because it is not animal-derived, D2 has long been the default form in plant-based products, though vegan D3 made from lichen is now widely available too. Most retail D3 supplements are made from lanolin, the waxy substance from sheep wool, which is why the vegan distinction matters to some readers.
Fortified foods are not a trivial source. Research suggests that fortification can move the blood marker meaningfully, since a randomized controlled trial in adolescents reported higher serum total and free 25-hydroxyvitamin D with daily intake of cholecalciferol-fortified skim milk 1.
This page does not recommend products or amounts. What matters for the question at hand is simply that the form written on the ingredient line tells you which molecular pathway your body is about to use, and that both pathways converge on the same blood marker.
Both forms take the same two-step activation route, which is why one blood test can capture both. Whether vitamin D arrives from skin synthesis, food or a supplement, it is picked up by vitamin D binding protein and carried to the liver. There, an enzyme adds a hydroxyl group at the 25 position, producing 25-hydroxyvitamin D, also called calcifediol. D2 becomes 25-hydroxyvitamin D2 and D3 becomes 25-hydroxyvitamin D3.
This intermediate is the circulating storage form. It persists in the blood for weeks rather than hours, it is not tightly regulated minute to minute, and it tracks overall supply reasonably well. Those three properties are exactly why laboratories measure it rather than measuring vitamin D itself, which clears from the blood quickly, or the active hormone, which the body defends within a narrow band.
The second step happens mainly in the kidney, where another enzyme adds a hydroxyl group at the 1 position to produce 1,25-dihydroxyvitamin D, or calcitriol. That is the active hormone. It binds the vitamin D receptor inside cells, changes which genes are transcribed, and increases calcium and phosphate absorption from the gut, among many other effects. Parathyroid hormone, calcium, phosphate and FGF23 all influence how much of this activation step occurs.
The practical consequence is that the storage form is the honest reporter of supply. Active hormone can look normal even when supply is low, because the body increases activation to compensate, which is one reason clinicians rarely order the active form for routine assessment.
The two forms share a destination but differ in origin, stability and measured effect on the blood marker.
| Feature | Vitamin D2 (ergocalciferol) | Vitamin D3 (cholecalciferol) |
|---|---|---|
| Natural origin | Ultraviolet-exposed fungi and yeast, including UV-treated mushrooms | Human and animal skin exposed to UVB, oily fish, egg yolk, liver |
| Usual supplement source | Yeast-derived ergosterol | Lanolin from sheep wool, or lichen for plant-based versions |
| Made inside the human body | No | Yes, in the skin |
| Liver converts it to | 25-hydroxyvitamin D2 | 25-hydroxyvitamin D3 |
| Counted in a total 25(OH)D result | Usually yes, though assay sensitivity to it varies | Yes |
| Effect on total 25(OH)D in pooled trials | Raises it, generally by less than D3 23 | Generally the larger and steadier rise 23 |
| Typical use today | Plant-based products, some fortified foods, specific clinician-supervised situations | Most retail supplements and most fortified dairy |
Both entries in that table are real vitamin D. Neither is inert, and neither is a substitute for the other in the sense of being identical. The differences are matters of degree, and degree is what shows up on a repeat blood test.
The weight of the evidence favours D3 for raising total 25-hydroxyvitamin D 2 3. Research suggests that, across pooled randomized trials, supplementation with the D3 form raises serum 25-hydroxyvitamin D more than the D2 form at comparable intakes 2. A later systematic review and meta-analysis reached a similar conclusion for daily supplementation and also looked at the separate D2 and D3 fractions rather than only the combined total 3.
A review focused specifically on older adults reported that the available comparisons favour cholecalciferol over ergocalciferol for raising and maintaining the blood marker in that group 4. That is a population where absorption, skin synthesis capacity and habitual sun exposure all tend to be lower, so the comparison matters more there than it might in a younger person who spends time outdoors.
Two caveats keep this honest. First, D2 is not useless. It raises 25-hydroxyvitamin D, and in many of these trials it moved the number in the right direction, just by less 2 3. Second, the gap between the forms appears to depend on how the compound is given, how often, and over what period.
What that means for you is modest and practical. If your number is not moving the way you and your clinician expected, the form on the label is one of several variables worth examining.
The leading explanations centre on transport and breakdown, and they remain explanations rather than settled facts. The vitamin D binding protein that carries these molecules through the blood appears to hold 25-hydroxyvitamin D3 somewhat more tightly than 25-hydroxyvitamin D2, which would keep the D3 version in circulation longer. The enzymes that inactivate vitamin D metabolites also appear to handle the two side chains differently, which would mean the D2 version is cleared faster.
There is a second, more surprising observation. Studies indicate that taking the D2 form raises the 25-hydroxyvitamin D2 fraction while the 25-hydroxyvitamin D3 fraction tends to fall at the same time, which blunts the net change in the total number 3. In other words, adding D2 does not simply stack on top of whatever D3 you already had. Part of the gain is offset.
None of this makes D2 the wrong molecule. It makes the two forms behave differently over time, which is most visible when someone retests after several weeks or months and finds a smaller change than expected. Stability matters more than a single peak value, because the storage marker is meant to reflect sustained supply rather than what happened yesterday.
These mechanisms are not demonstrated directly in every population, so treat them as uncertain rather than as a closed question.
Usually not, because most laboratories report a single combined total. Total 25-hydroxyvitamin D is the sum of the 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 fractions, and on a standard report those two components are invisible. Liquid chromatography tandem mass spectrometry can separate and report them individually, and research studies often do exactly that 3, but routine panels generally do not.
This matters for two reasons. The first is interpretation. Someone taking a D2 product may carry a meaningful share of their total as the D2 fraction, and some immunoassays detect that fraction less reliably than the D3 fraction, which can make a total look lower than the underlying supply. The second is consistency. Different assay platforms do not always agree perfectly with one another, so comparing a result from one laboratory with a result from another can introduce a difference that has nothing to do with your biology.
The practical move is to keep your testing consistent, use the same laboratory and method where you can, and compare trends rather than isolated values. Also check the units. Some reports use ng/mL and others use nmol/L, and the nmol/L figure is roughly two and a half times the ng/mL figure, so a number that looks alarming at first glance is often the same value in a different unit.
Yes, body size appears to be one of the strongest modifiers of the response. Vitamin D is fat soluble, so it distributes into adipose tissue, and a larger total volume of distribution means the same intake produces a smaller rise in the blood concentration. This is often described as volumetric dilution rather than a defect in absorption.
In pooled analyses comparing the two forms, higher body mass index is associated with a smaller increase in serum 25-hydroxyvitamin D for a given intake, which is why the 2024 systematic review treated body mass index as a factor worth analysing rather than a footnote 3. The comparison between D2 and D3 does not disappear in people with higher body mass index, but the absolute size of the change in the number can be smaller in that group.
The same logic runs the other way. Changes in body composition over months can shift the marker without any change in intake or sun exposure, which is one reason a result that moves between tests does not automatically mean that a product stopped working.
For anyone tracking this marker alongside a training and nutrition plan, the useful habit is to read the vitamin D number next to weight and body composition data rather than in isolation. Context turns a confusing value into an interpretable one, and your clinician is the right person to do that interpreting.
Yes, several, and they are legitimate rather than leftovers. The most common is preference. D2 is fungal in origin, so it fits plant-based diets without needing the lichen-derived version of D3. Availability is another factor, since some fortified foods and some regional product ranges use ergocalciferol as standard.
Clinically supervised situations are the more interesting category. Research in people who have had bariatric surgery has examined ergocalciferol regimens as a way to improve vitamin D status in a group where fat absorption is altered by the procedure itself, with the reported findings suggesting measurable improvement in that setting 5. In kidney medicine, a review of ergocalciferol and cholecalciferol in people with chronic kidney disease set out how the two forms are used and how they differ in raising 25-hydroxyvitamin D in that population 6, where mineral metabolism is complicated by altered activation in the kidney.
This page gives no amounts, schedules or product recommendations, and it names no prescription products. Where a specific form, strength or supervised regimen is under consideration, a licensed provider evaluates whether it is appropriate based on your history, your kidney function, your absorption and your current results. That evaluation is the whole point, because the right answer in malabsorption is not the right answer for someone with normal digestion and a mildly low number.
Sunlight makes D3, and it makes it only under fairly specific conditions. The relevant wavelength is ultraviolet B, which converts 7-dehydrocholesterol in the skin into previtamin D3. Ordinary window glass blocks most UVB, which is why time in a sunny room does not count. The angle of the sun matters too, so latitude, season and time of day all determine whether the necessary wavelength reaches the ground at all.
Several personal factors change the yield. Melanin absorbs ultraviolet light, so more deeply pigmented skin produces less vitamin D for the same exposure. Skin concentration of the precursor declines with age. Sunscreen, clothing and indoor work all reduce exposure, and that is often a reasonable trade, since ultraviolet exposure also carries skin cancer risk that no vitamin D consideration cancels out.
One reassuring detail is that skin synthesis is self-limiting. Prolonged ultraviolet exposure diverts the precursor into inactive photoproducts, so sun exposure does not drive vitamin D to excess the way very large sustained oral intakes potentially can.
The net effect is high variability between people and across the year, which is exactly why a measured blood value beats an estimate based on lifestyle. Two people with similar routines can land in very different places on the same marker, and only a test tells them apart.
Mixed results, and the distinction between correcting a low level and adding more to an already sufficient one explains much of that mixture.
In bone health, a randomized controlled trial in generally healthy older adults examined vitamin D3, omega-3 fatty acids and a simple strength training programme and did not report a significant benefit of vitamin D3 on the bone outcomes measured 7. A related analysis from the same three-year trial looked at change in physical activity and likewise did not report that vitamin D3 increased activity levels 8. In mood, a large randomized clinical trial of long-term vitamin D3 against placebo did not report a reduction in the risk of depression or clinically relevant depressive symptoms, nor a difference in mood scores 9.
One randomized trial examined whether vitamin D3 influenced asymmetric and symmetric dimethylarginine, laboratory markers studied in relation to blood vessel function, in people with arterial hypertension 10. In chronic kidney disease, a double-blind randomized trial compared cholecalciferol and calcitriol for measures of vascular function 11, and a separate study examined whether cholecalciferol supplementation changed angiogenic markers in that population 12.
The honest summary is that raising a low storage level is well supported as a goal, while extra supply in people who already have enough has not consistently produced the downstream benefits that observational data once suggested.
Quite a lot, which is why the form on the label is only one input. Season and recent sun exposure often account for a swing between a winter result and a summer result in the same person. Skin tone, age and the amount of skin regularly uncovered all shift baseline production.
Absorption is the next major variable. Vitamin D needs dietary fat to be absorbed well, so in people with fat malabsorption, inflammatory bowel conditions, coeliac disease or a history of bariatric surgery, oral intake translates into blood level less efficiently. Body composition, as described above, changes distribution. Pregnancy and lactation alter demand.
Medication is another consideration. Certain medicine classes are known to speed up the breakdown of vitamin D metabolites, and a clinician reviewing your medication list can factor that in. Kidney and liver function affect the two activation steps directly.
Finally, there are laboratory and timing factors. Assay platforms differ, the same sample can produce slightly different values on different methods, and a test taken soon after a large recent intake does not represent your usual state. Taken together, these explain most of the surprising results people bring to a consultation, long before anything unusual needs to be considered.
Vitamin D makes most sense read as part of a mineral and bone panel rather than alone. Serum calcium, ideally interpreted with albumin, shows whether calcium handling is being affected. Parathyroid hormone is the key partner marker, because it tends to rise when vitamin D supply is low and the body is working harder to maintain calcium, and it can clarify whether a modestly low vitamin D value is having any functional consequence.
Phosphate, magnesium and alkaline phosphatase round out the picture. Magnesium deserves a mention because it is a cofactor for the enzymes that hydroxylate vitamin D, so magnesium status can influence how the system functions. Alkaline phosphatase can reflect bone turnover. Creatinine with eGFR matters because the kidney performs the activation step, and liver markers matter for the first hydroxylation.
This is the reasoning behind broad panels rather than single tests. FitScript builds its membership around 150+ biomarkers tested per year, with interpretation from Atlas, FitScript's AI health advisor, so a vitamin D value is read next to the markers that give it meaning rather than on its own.
No single marker in that group diagnoses anything by itself. The pattern across several of them, combined with your history and symptoms, is what a clinician actually uses.
Any result outside the standard reference range is worth a conversation, and so is a result inside the range that does not match how you feel. A low or suboptimal value raises questions about intake, absorption, sun exposure and body composition, and the answer differs depending on which of those is driving it.
A high result deserves attention too. Very high sustained intakes can raise blood calcium, and symptoms such as unusual thirst, frequent urination, nausea, constipation or confusion alongside a high vitamin D value are worth discussing with a clinician promptly. Sun exposure does not produce that picture, because skin synthesis is self-limiting, so the usual context is supplementation.
Other situations that justify a review include a history of kidney stones, chronic kidney disease, parathyroid conditions, sarcoidosis or other granulomatous conditions, malabsorption, pregnancy, and the use of medications that affect vitamin D metabolism. In people with those circumstances, the interpretation of the same number can be quite different.
This article is educational and is not medical advice. Discuss your results and any supplement or therapy decision with a clinician or licensed provider who can see your full history, your current medications and the rest of your laboratory picture, and never ignore an abnormal result because a general article suggested a benign explanation.
No. Vitamin D is the family name for a group of related compounds, and D3 (cholecalciferol) is one member of that family. The other form used in food and supplements is D2 (ergocalciferol). A label that says only 'vitamin D' is incomplete, so check the ingredient line for cholecalciferol or ergocalciferol.
Most laboratories report total 25-hydroxyvitamin D, which is the combined sum of the 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 fractions. Specialised mass spectrometry methods can report the two fractions separately, but routine panels show one number. If you want to compare results over time, use the same laboratory and method where possible.
D3 generally raises serum 25-hydroxyvitamin D more than D2 at comparable intakes. D2 still raises the marker, so it is not inert. The difference is one of degree, and it becomes visible on a repeat test rather than immediately.
Not always. Most retail D3 supplements are made from lanolin, which comes from sheep wool, but D3 derived from lichen is widely available and suits plant-based diets. D2 is fungal in origin and has historically been the default plant-based option. The form is listed on the ingredient panel rather than the front of the package.
Human skin makes D3 only. Ultraviolet B light converts 7-dehydrocholesterol in the skin into previtamin D3, which becomes cholecalciferol. D2 is produced when ultraviolet light acts on ergosterol in fungi and yeast, which is why ultraviolet-exposed mushrooms contain it. Window glass blocks most UVB, so indoor sunlight contributes little.
A typical laboratory reference range for 25-hydroxyvitamin D runs 30 to 100 ng/mL, and FitScript's optimal range for this marker is 50 to 80 ng/mL. Optimal ranges of that kind are optimization targets, not diagnostic cut-offs, and reference ranges vary by lab, age and sex. Some reports use nmol/L instead, so check the units.
Several factors can blunt the change. Body size matters, because vitamin D distributes into fat tissue and a larger volume of distribution means a smaller rise. Fat absorption, season, sun exposure, age, certain medication classes and laboratory assay differences all contribute. The form taken is one variable among those, and a clinician can help work through which applies.
Discuss any value outside the standard reference range, and any value that does not match your symptoms. A high result with unusual thirst, frequent urination, nausea or confusion is worth discussing with a clinician promptly. A history of kidney stones, chronic kidney disease, parathyroid conditions, sarcoidosis, malabsorption or pregnancy also changes how the same number should be interpreted.